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 Abstract 
Background 
Successful revascularization after endovascular therapy for acute ischemic stroke is measured by 
TICI score, yet variability exists in scale definitions and use. We examined the degree of 
reperfusion with the expanded TICI (eTICI) scale and the association with outcomes in the 
HERMES collaboration of recent endovascular trials. 
Methods and Results 
An independent reader of the HERMES Imaging Core, blind to all other data, evaluated the 
angiography of subjects treated with endovascular therapy in HERMES. A battery of various 
TICI scores (mTICI, TICI, oTICI2C) was used to define reperfusion of the initial target 
occlusion defined by noninvasive imaging and conventional angiography. Statistical analyses 
examined all TICI reperfusion metrics and correlation with clinical outcomes. Angiography of 
801 subjects was available, including 797 defined by non-invasive imaging (154 ICA, 583 M1, 
60 M2) and 748 by conventional angiography (195 ICA, 459 M1, 94 M2). Among 729 subjects 
in whom reperfusion grade could be established, using eTICI (3=100%, 2C=90-99%, 2b67=67-
89%, 2b50=50-66%) of the conventional angiography target occlusion, there were 63 eTICI 3 
(9%), 166 eTICI 2c (23%), 218 eTICI 2b67 (30%), 103 eTICI 2b50 (14%), 100 eTICI 2a (14%), 
19 eTICI 1 (3%) and 60 eTICI 0 (8%). Across the entire scale range, the TICI (AUC 0.657), 
TICI 2C (AUC 0.661) and eTICI (AUC 0.664) showed similar receiver-operator characteristics 
for association of reperfusion with better clinical outcomes, with eTICI the highest numerical 
AUC.  All three of these were statistically superior to the mTICI c-statistic (0.634) (p=0.013 for 
eTICI vs mTICI in particular). mRS shift analyses from baseline to 90 days revealed increasing 
 TICI grades were linked with better outcomes, with significant distinctions between TICI 0/1 vs 
2a (p=0.028), 2a vs 2b50 (p=0.017) and 2b50 vs 2b67 (p=0.014).  
Conclusions 
The benefit of endovascular therapy in HERMES was strongly associated with increasing 
degrees of reperfusion defined by eTICI. Since the eTICI metric identified meaningful 
distinctions in clinical outcomes, it should be used in future studies and routine practice of 
endovascular therapy. 
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  Endovascular therapy is a highly effective treatment for acute ischemic stroke caused by 
large artery occlusion in the anterior cerebral circulation, significantly increasing the likelihood 
of recovery to independence.1 Reperfusion of the ischemic territory downstream from an arterial 
occlusion is the therapeutic mechanism responsible for benefit. The extent of reperfusion, 
however, may vary across individual cases depending on numerous factors, including the degree 
of collateral circulation.2-5 Most commonly, reperfusion is evaluated on angiography performed 
immediately after recanalization or when reopening of the arterial occlusion is achieved.   
Several iterations of the Thrombolysis In Cerebral Infarction (TICI) score, adapted from 
the TIMI coronary circulation scoring system to the cerebral circulation have been used to 
quantify reperfusion.6 Successive refinements of the original TICI scale were implemented to 
enhance standardization for different sites of arterial occlusion and to optimally discern subtle 
distinctions in the amount of blood flow restored after thrombectomy. Multiple studies have 
examined the inter-rater reliability of TICI grades. Variability exists, however, in definitions, 
nomenclature, use and reporting. Consensus recommendations for angiographic revascularization 
standards developed in 2013 defined successful reperfusion by a modified TICI (mTICI) score 
signifying filling of 50% or more of the downstream territory.7  
 Reperfusion of the ischemic territory downstream from an arterial occlusion in stroke is 
distinct from recanalization, defined as restoring patency in the occluded arterial segment.8, 9 
Reperfusion specifically refers to re-establishing blood flow via normal arterial routes, in 
contrast to indirect collateral perfusion. The extent of reperfusion is quantified by the percentage 
of the downstream territory and is therefore dependent on defining the specific site of initial 
arterial occlusion. Such measurement of reperfusion is most often conducted on biplane 
angiography where the three-dimensional nature of the arterial territory must be inferred. 
 Grading the extent of reperfusion or assigning a TICI score is typically conducted by the local 
operator or treating physician at the end of the procedure. Achieving a favorable TICI grade is 
considered a quality metric for endovascular stroke therapy. Rating is influenced by local rater 
experience and central core-lab adjudication is commonly more conservative compared to local 
ratings. Since the original description of TICI 15 years ago, several intermediate grades of 
reperfusion have been introduced without a clear rationale for such scale modifications. The 
entire range of grade 2 TICI reperfusion, extending from a minimum of any distal branch filling 
to almost complete downstream perfusion, has been subdivided and confusingly labeled with 
inconsistent terminology.  
Availability of data from reperfusion trials now allows critical review of TICI reperfusion 
grade definitions. Standardization of TICI grading is essential for clinical practice and for future 
trials. We examined the relationship of reperfusion grades and clinical outcomes using individual 
patient data in the Highly Effective Reperfusion Evaluation in Multiple Endovascular Stroke 
(HERMES) trials that comprise the majority of randomized, controlled trials undertaken with 
modern endovascular treatments.10 Data were systematically analyzed by an experienced core lab 
to delineate TICI reperfusion and substantiate prior scale distinctions with the associated clinical 
outcomes after stroke treatment. 
 
Methods 
Study Design 
HERMES included 7 distinct endovascular therapy trials that established the efficacy of 
mechanical thrombectomy for acute ischemic stroke. Detailed methodology of each trial has 
been previously reported.11-13 In HERMES, the entire imaging and angiography datasets of the 7 
 participating trials were centrally pooled in the Neurovascular Imaging Research Core at UCLA. 
Anonymized images of each enrolled subject were indexed and relabeled by a randomly assigned 
HERMES subject identification number to mask any possible association with the original 
randomized controlled trial. In each of the original trials, only the subjects randomized to 
endovascular therapy underwent angiography. As a result, the HERMES angiography dataset 
reflects solely those subjects assigned to endovascular therapy.  
 
Angiography Core Laboratory Evaluation 
The HERMES angiography dataset was analyzed by an independent core laboratory with 
extensive experience in adjudication of imaging and angiography from numerous multicenter 
stroke trials and registries. The angiography images were provided to the core lab without any 
additional information other than the site of the initial target occlusion determined by 
noninvasive imaging in the original trial. As technical differences in imaging technique, or 
dynamic changes in occlusion due to recanalization or distal thrombus migration may occur 
between baseline noninvasive imaging and conventional angiography, a distinction was made 
between reperfusion of the target occlusion defined by non-invasive imaging and by 
conventional angiography at the start of the endovascular procedure, defined as the most 
proximal lesion visualized at the procedure start, not necessarily the location of device 
deployment or mechanical thrombectomy. For instance, a terminal internal carotid artery (ICA) 
occlusion visualized on conventional angiography may be defined as the conventional 
angiography target occlusion in a case where thrombectomy is performed in the more distal 
middle cerebral artery (MCA). 
 The HERMES angiography core lab performed a quality assessment of the angiography 
data, denoting availability, adequacy and limiting factors associated with each subject’s data. As 
TICI reperfusion in the downstream territory is critically contingent on the specific location of 
the arterial occlusion, it was imperative that a diagnostic run or contrast injection of the 
occlusion was available at the procedure start to determine the conventional angiography target 
occlusion location. Similarly, a final run or diagnostic injection of the same arterial territory was 
required to determine TICI reperfusion. In addition, the angiography core lab noted when limited 
data were available, such as the lack of biplane angiography or failure to acquire adequate runs 
that precluded evaluation of reperfusion. A battery of various TICI scores in this study 
population (Table 1) was used to define reperfusion of the initial target occlusion on noninvasive 
imaging and conventional angiography. This 7-point compilation of TICI grades, termed the 
expanded TICI or eTICI, reflects all previously reported thresholds used to define reperfusion 
after endovascular stroke therapy. In brief, eTICI grade 0 is equivalent to no reperfusion or 0% 
filling of the downstream territory; eTICI 1 reflects thrombus reduction without any reperfusion 
of distal arteries; eTICI 2a is reperfusion in less than half or 1-49% of the territory; eTICI 2b50 is 
50-66% reperfusion, exceeding the modified TICI (mTICI) 2B threshold but below the original 
TICI 2B cutpoint; eTICI 2b67 is 67-89% reperfusion, exceeding TICI but below TICI 2C; eTICI 
2c is equivalent to TICI 2C or 90-99% reperfusion; and eTICI 3 is complete or 100% 
reperfusion, tantamount to TICI 3. Multiple studies have already examined the inter-rater 
reliability of all the components of the eTICI.14, 15 In order to define the inter-rater reliability of 
the distinction between eTICI 2b50 (50-66% reperfusion, mTICI 2B) and eTICI 2b67 (67-89% 
reperfusion, TICI 2B), a cohort of 52 subjects was rated independently by 2 readers. 
 
 Statistical Analyses 
Descriptive methods were used to characterize baseline angiographic features, including 
distributions across categories. For each HERMES subject, the blinded evaluation of the 
conventional angiography target occlusion location was noted and compared with the initial 
target occlusion location for each case. Inter-rater reliability was analyzed using a correlation 
coefficient and Cohen’s kappa statistic. The distribution of eTICI scores for the conventional 
angiography target occlusion was described and analyzed with respect to the key stroke outcome 
variable of the modified Rankin score (mRS) at 90 days. Graphical analyses were also used to 
describe the distribution of mRS at day 90 stroke clinical outcomes for each eTICI grade. mRS 
distribution analyses at day 90 were used to compare clinical outcomes between neighboring 
eTICI thresholds, with statistical comparisons by Wilcoxon’s rank-sum test for nonparametric 
analysis. Finally, receiver operating characteristic (ROC) curves were constructed to illustrate 
the discriminative value of various TICI classification schemes on the mRS outcomes. The ROC 
results were described by the area under the curve (AUC) statistic and associated p-values 
computed by the method of DeLong. For all analyses, a two-tailed p-value less than 0.05 was 
considered statistically significant, without adjustment for multiple testing. Analyses were 
performed using SAS version 9.3 (SAS Institute, Cary, NC, USA) and R version 3.2 (R 
Foundation for Statistical Computing, Vienna, Austria). 
 
Results 
Arterial Occlusions 
Angiography was available in a total of 801 subjects in HERMES, reflecting 801/871 
(92%) of patients assigned to the endovascular treatment arms of the 7 participating trials. The 
target occlusion on non-invasive imaging was located at the ICA in 154 (19%), proximal MCA 
 or M1 in 583 (73%) and M2 arterial segment in 50 (6%), and on conventional angiography at the 
ICA in 195 (24%), proximal MCA or M1 in 459 (57%) and M2 arterial segment in 94 (12%). 
  
Extent of Reperfusion on eTICI  
The extent of reperfusion was distributed across the entire range of the eTICI scale, 
including the spectrum from absolutely no reperfusion to complete restoration of flow in the 
territory downstream of the conventional angiography target occlusion.  Among the 801 subjects 
noted above, reperfusion grade could not be established due to imaging limitations in 72, giving 
729 evaluable eTICI scores. No reperfusion or eTICI 0 was noted in 60 (8%) and only reduction 
in thrombus without filling of distal arterial branches or eTICI 1 in 19 (3%). Reperfusion in less 
than half the territory or eTICI 2a was noted in 100 (14%). Reperfusion in 50-66% of the 
territory or eTICI 2b50, equivalent to mTICI 2B yet less than TICI 2B, was noted in 103 (14%). 
Restoration of flow in 67-89% of the territory or eTICI 2b67, above the TICI 2B threshold yet 
less than TICI2C, occurred in 218 (30%). Extensive reperfusion between 90-99%, or eTICI 2c 
equivalent to TICI 2C, was noted in 166 (23%). Finally, complete or full reperfusion of eTICI 3, 
equivalent to TICI 3, was found in only 63 (9%).  
 The distinctions between individual eTICI grades and the resultant discriminant ability of 
these perfusion categories was critically dependent on the availability of adequate angiographic 
views. Diagnostic confidence or potential limitations in the separation of eTICI categories was 
documented in 25/729 (3%) of subjects. The most common difficulty occurred at the 
intermediate eTICI grades that demarcated eTICI 2b50 from eTICI 2b67, demarcating 
reperfusion thresholds around the 67% level (Figure 1). Interestingly, the subtle distinction of 
eTICI 2c and 3, discriminating the TICI 2C (90-99%) category from full or TICI 3 (100%) 
 categories (Figure 2) occurred in only 8/729 (1%). Within the eTICI 2c or TICI 2C category, 
overt distal emboli manifest as vessel cutoffs or menisci were visualized in 67/166 (40%). 
 Inter-rater reliability for the distinction between eTICI 2b50 and 42b67 (mTICI 2B versus 
TICI 2B) revealed an agreement of 92% (48/52), with a Cohen’s kappa statistic of k=0.83, 
p<0.001. 
 
Relationship of eTICI Reperfusion and Clinical Outcomes 
Graphical depictions of the relationship between eTICI reperfusion grades and 
subsequent clinical outcomes of mRS at 90 days revealed that more extensive reperfusion was 
associated with better outcomes (Figure 3). There was an unequivocal, graded pattern of 
increased proportion of subjects with no or minimal disability (mRS 0-1) hierarchically linked 
with higher eTICI grades. Similarly, the proportion of severe disability or death (mRS 5-6) was 
less with higher eTICI grades. Interestingly, even intermediate levels of disability (mRS 2-4) 
exhibited a clear relationship of decreasing disability with more extensive reperfusion. It should 
be noted, however, that across almost all eTICI reperfusion grades, there was still a broad 
distribution of mRS day 90 clinical outcomes. 
Direct comparison of the distribution in clinical outcomes of individual, neighboring 
eTICI grades revealed specific differences between reperfusion categories (Table 2). The 
relatively small number of subjects with extremely limited (eTICI 0-1) or complete (eTICI 3) 
reperfusion may have limited such distinctions between eTICI categories at the extreme ends of 
the scale, whereas differences between intermediate categories of reperfusion were more 
apparent. The distribution of clinical outcomes was clearly different between eTICI grades 0/1 
 versus 2a, 2a versus 2b50, and 2b50 versus 2b67 that demarcate the extent of reperfusion at any 
versus none, 50%, and the 67% thresholds, respectively.  
 ROC curve analyses (Figure 4) showed similar performance of TICI (AUC 0.657), TICI 
2C (AUC 0.661) and eTICI (AUC 0.664) in discriminating better clinical outcomes.  All three of 
these were statistically superior to the mTICI AUC (0.634) (p=0.013 for eTICI vs mTICI in 
particular). 
 
Discussion  
Our study demonstrates that grades of better reperfusion are incrementally associated 
with better clinical outcomes. The use of all previously described TICI variants demonstrates the 
utility of using an expanded or eTICI scale that encompasses these prior scale definitions. We 
also demonstrated that these eTICI grades are linked with subsequent clinical outcomes after 
stroke therapy, providing a cogent rationale for future adoption and largescale use of eTICI. 
However, while more extensive reperfusion is associated with better clinical outcomes, a wide 
range of outcomes was evident even at the extremes of poor and full reperfusion, indicating that 
additional factors remain important determinants of outcome. 
 We confirmed a predominance of M1 occlusions with considerably fewer ICA or M2 
occlusions, as reported in individual trials and in previous pooled analyses. We noted that the 
target occlusion defined on conventional angiography at procedure start differed from that on 
baseline noninvasive imaging. This may result from interval recanalization or thrombus 
migration, or alternatively be ascribed to technical differences in acquisition of non-invasive 
versus invasive imaging techniques. Based on the conventional angiography target occlusion site 
determined by our HERMES core lab, we corroborate the reperfusion rates reported in the 
 original trial reports, exhibiting substantial predominance of flow restoration to much of the 
ischemic territory. Importantly, however, the proportion of complete or full reperfusion was 
substantially less than originally described. There were key distinctions in reperfusion categories 
when specific thresholds were used to subdivide the ischemic territory. Established consensus 
recommendations for angiographic standards in endovascular therapy have defined successful 
reperfusion as exceeding 50% of the territory.7 We have demonstrated, however, that within the 
>50% reperfusion category, a considerable number of cases fell into previously-defined finer 
subdivisions of 50-66%, 67-89% and 90-99%, and that these refinements identify meaningful 
differences in clinical outcomes. 
  Our use of all previously defined TICI categories, redefined as eTICI grades, 
demonstrated that such categories identify gradation of outcomes associated with the extent of 
reperfusion. Comparison of adjacent or ordinal reperfusion grades on the eTICI scale showed 
that clinical outcomes vary between each grade, with more pronounced differences within 
intermediate eTICI categories. Prior studies have provided preliminary evidence that, compared 
with less granular TICI scales, the more fine-grained TICI scales have added prognostic value 
and clinical utility.16-20 The prior studies have been relatively small and with limited geographic 
scope, limiting their precision and generalizability. We therefore undertook the current study to 
validate and quantify the superiority of the eTICI in the large, multinational HERMES data set. 
We have extended previous reports concerning inter-rater reliability of eTICI cutpoints by 
demonstrating excellent reliability for distinguishing eTICI 2b50 and 2b67 (mTICI 2B versus 
TICI 2B).14, 15 
Although this analysis establishes that the 7-point eTICI scale predicts increasingly better 
clinical outcomes, it is important to note that even at the extreme ends of the scale a wide 
 distribution of outcomes may be evident. For example, not all subjects with eTICI 0/1 
reperfusion have poor clinical outcomes and conversely, there are subsets of patients with eTICI 
2c or 3 reperfusion with outcomes of severe disability or death. Such examples suggest that 
angiographic outcomes alone have limited utility for clinical outcome prediction. The AUC 
values for predicting good clinical outcomes were higher for eTICI 2b67 or 2c (>66% or >90%, 
respectively) compared with eTICI 3 (>50%), yet such AUC values of 0.66 are relatively 
modest, at best. Factors beyond reperfusion, including the underlying pathophysiology such as 
extent of established tissue injury, or collateral circulation, clinical variables, or subsequent 
events, such as recurrent stroke, likely influence clinical outcomes. It also remains unclear 
whether the cause of limited reperfusion, due to distal emboli or increased downstream 
resistance, have different impact in clinical outcomes, even when reperfusion is almost complete 
as in eTICI 2c or TICI 2C flow. 
 Limitations of our systematic angiographic evaluation in HERMES include the 
availability of adequate images, already restricted to subjects in the endovascular arm of these 
randomized, controlled trials. Evaluation of reperfusion may have been limited by incomplete 
depiction of the conventional angiography target occlusion or final diagnostic runs with biplane 
angiography. Aside from potentially missing data, variations in technique or local practice may 
have precluded adequate visualization of key angiography data. We did not account for the time 
required to achieve final eTICI reperfusion or consider local factors that may have influenced the 
duration of the procedure.21 Such challenges in blinded readings may not capture subtle aspects 
apparent at the time of intervention. In addition, wider application of any rating scale requires 
examination. 
 In sum, the benefit of endovascular therapy in HERMES was strongly associated with 
increasing degrees of eTICI reperfusion. The eTICI scale reveals important distinctions in the 
degree of reperfusion with respect to clinical outcomes, underscoring the need to implement 
standard methodology for reporting of angiography in stroke treatment in trials and routine 
practice. eTICI provides granularity in distinguishing the extent of reperfusion that is clinically 
meaningful. Defining successful reperfusion should be linked with good clinical outcomes, 
making it unlikely that a single threshold of eTICI reperfusion will work in all cases. Our 
analyses suggest that if a dichotomous threshold were to be used for the definition of successful 
reperfusion, then eTICI 2b67, equivalent to TICI 2B, is optimal. 
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Figure Legend 
Figure 1. Angiography of final reperfusion of the MCA territory, revealing (A) eTICI 2b50=50-
66% versus (B) eTICI 2b67 = 67-89%. 
 
Figure 2. Angiography of final reperfusion of the MCA territory, revealing (A) eTICI 2c=90-
99% versus (B) eTICI 3 = 100%. 
 
Figure 3. Graphical depiction of mRS outcomes at 90 days based on eTICI grades. 
 
Figure 4. ROC curves showing the predictive ability of various TICI grades with respect to 
clinical outcomes, using mRS (0-1) and mRS (0-2). 
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Table 1. Study population 
 
Characteristic 
Mean ± SD (N) 
Median (IQR) 
or % (n/N) 
Age (years) 65.4 ± 13.5 (729)   [67.0] (56.8, 76.0) 
Female sex 47.5% (346/729) 
NIHSS at baseline 17.1 ± 4.8 (725)   [17.0] (14.0, 20.0) 
ASPECTS at baseline 7.6 ± 1.8 (722)   [8.0] (7.0, 9.0) 
Collateral grade   
   0  0.9% (5/562) 
   1 13.7% (77/562) 
   2 44.3% (249/562) 
   3 41.1% (231/562) 
tPA delivered 85.7% (625/729) 
Onset to randomization (min) 205.7 ± 96.9 (728)   [184.5] (140.5, 246.3) 
Onset to arterial puncture (min) 252.6 ± 96.8 (685)   [240.0] (185.0, 300.0) 
eTICI category post-procedure   
   0  8.2% (60/729) 
   1  2.6% (19/729) 
   2a (0-49%) 13.7% (100/729) 
   2b50 (50-66%) 14.1% (103/729) 
   2b67 (67-89%) 29.9% (218/729) 
   2c 22.8% (166/729) 
   3  8.6% (63/729) 
 
 
  
Table 2. Distinctions between eTICI categories with respect to clinical outcomes 
eTICI 
mRS 0 
% (n/N) 
mRS 1 
% (n/N) 
mRS 2 
% (n/N) 
mRS 3 
% (n/N) 
mRS 4 
% (n/N) 
mRS 5 
% (n/N) 
mRS 6 
% (n/N) 
0  0.0% (0/59) 3.4% (2/59) 18.6% (11/59) 5.1% (3/59) 33.9% (20/59) 6.8% (4/59) 32.2% (19/59) 
1 0.0% (0/19) 5.3% (1/19) 15.8% (3/19) 10.5% (2/19) 21.1% (4/19) 5.3% (1/19) 42.1% (8/19) 
2a (0-49%) 10.0% (10/100) 6.0% (6/100) 13.0% (13/100) 14.0% (14/100) 25.0% (25/100) 10.0% (10/100) 22.0% (22/100) 
2b50 (50-66%) 4.9% (5/103) 16.5% (17/103) 25.2% (26/103) 14.6% (15/103) 18.4% (19/103) 7.8% (8/103) 12.6% (13/103) 
2b67 (67-89%) 13.3% (29/218) 21.1% (46/218) 17.9% (39/218) 23.4% (51/218) 10.1% (22/218) 5.0% (11/218) 9.2% (20/218) 
2c 14.5% (24/165) 22.4% (37/165) 20.0% (33/165) 17.0% (28/165) 12.1% (20/165) 4.8% (8/165) 9.1% (15/165) 
3 12.7% (8/63) 36.5% (23/63) 19.0% (12/63) 9.5% (6/63) 11.1% (7/63) 4.8% (3/63) 6.3% (4/63) 
 
       
 
 
